Mandate

Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m

April 22, 2020 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with raising of capital from new and current shareholders in an investment round in a total amount of approximately SEK 148 million.

The issue occurs at a valuation of Lendify of approximately SEK 1.5 billion (prior to the investment).

Vinge’s team primarily consisted of partner Jonas Johansson together with associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026